• Cordingley, F.T., Hoffbrand, A.V., Heslop, H.E., Turner, M., Bianchi, A., Reittie, J.E., Vyakarnam, A., Meager, A. & Brenner, M.K. (1988) Tumour necrosis factor as an autocrine tumour growth factor for chronic B-cell malignancies. Lancet, 1, 969971.
  • Fitzgibbon, J., Grenzellias, D., Matthews, J., Lister, T.A. & Gupta, R.K. (1999) Tumour necrosis factor polymorphisms and susceptibility to follicular lymphoma. British Journal of Haematology, 107, 388391.
  • Le Hir, M., Bluethmann, H., Kosco-Vilbois, M.H., Muller, M., Di Padova, F., Moore, M., Ryffel, B. & Eugster, H.P. (1996) Differentiation of follicular dendritic cells and full antibody responses require tumour necrosis factor receptor-1 signaling. Journal of Experimental Medicine, 183, 23672372.
  • Mclean, T.W., Ringold, S., Neuberg, D., Stegmaier, K., Tantravahi, R., Ritz, J., Koeffler, H.P., Takeuchi, S., Janssen, J.W.G., Seriu, T., Bartram, C.R., Sallan, S.E., Gilliland, D.G. & Golub, T.R. (1996) TEL/AML-1 dimerizes and is associated with a favorable outcome in childhood acute lymohoblastic leukemia. Blood, 88, 42524258.
  • Messer, G., Spengler, U., Jung, M.C., Honold, G., Blömer, K., Pape, G.R., Riethmüller, G. & Weiss, E.H. (1991) Polymorphic structure of the tumour necrosis factor (TNF) locus: An NcoI polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF-beta production. Journal of Experimental Medicine, 173, 209219.
  • Tracey, K.J., Wei, H., Manogue, K.R., Fong, Y., Hesse, D.G., Nguyen, H.T., Kuo, G.C., Beutler, B., Cotran, R.S. & Cerami, A. (1988) Cachectin/tumour necrosis factor induces cachexia, anaemia, and inflammations. Journal of Experimental Medicine, 167, 12111227.
  • Tsukasaki, K., Miller, C.W., Kubota, T., Takeuchi, S., Fujimoto, T., Ikeda, S., Tomonaga, M. & Koeffler, H.P. (2001) Tumour necrosis factor alpha polymorphism associated with increased susceptibility to development of adult T-cell leukemia/lymphoma in human T-lymphotropic virus type I carriers. Cancer Research, 61, 37703774.
  • Warzocha, K., Salles, G., Bienvenu, J., Bastion, Y., Dumontet, C., Renard, N., Neidhardt, E.M. & Coiffier, B. (1997) The tumour necrosis factor ligand-receptor system can predict treatment outcome in lymphoma patients. Journal of Clinical Oncology, 15, 499508.
  • Warzocha, K., Ribeiro, P., Bienvenu, J., Roy, P., Charlot, C., Rigal, D., Coiffier, B. & Salles, G. (1998) Genetic polymorphisms in the tumour necrosis factor locus influence non-Hodgkin's lymphoma outcome. Blood, 91, 35743581.
  • Wihlborg, C., Sjöberg, J., Intaglietta, M., Axdorph, U., Pisa, E.K. & Pisa, P. (1999) Tumour necrosis factor-α cytokine promoter gene polymorphism in Hodgkin's disease and chronic lymphocytic leukemia. British Journal of Haematology, 104, 346349.
  • Wilson, A.G., Symons, J.A., McDowell, T.L., McDevitt, H.O. & Duff, G.W. (1997) Effects of a polymorphism in the human tumour necrosis factor alpha promoter on transcriptional activation. Proceedings of the National Academy of Sciences of the United States of America, 94, 31953199.